Ghrelin - Integrative neuroendocrine peptide in health and disease

被引:91
作者
Wu, JT [1 ]
Kral, JG [1 ]
机构
[1] SUNY Downstate Med Ctr, Dept Surg, Brooklyn, NY 11203 USA
关键词
D O I
10.1097/01.sla.0000118561.54919.61
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objective: Ghrelin is a novel gastric hormone recognized in 1999 as a mediator of growth hormone release. Since growth hormone is anabolic, an important function of ghrelin may be to coordinate energy needs with the growth process. Newly discovered biologic roles of ghrelin imply that it may have other important physiological functions as well. This is a review of recent clinically relevant, yet less well-known, physiologic actions of ghrelin. Summary Background Data: Ghrelin has profound orexigenic, adipogenic, and somatotrophic properties, increasing food intake and body weight. Secreted predominantly from the stomach, ghrelin is the natural ligand for the growth hormone secretagogue receptor in the pituitary gland, thus fulfilling criteria of a brain-gut peptide. The brain-gut axis is the effector of anabolism by regulating growth, feeding, and metabolism via vagal afferents mediating ghrelin signaling. However, the wide tissue distribution of ghrelin suggests that it may have other functions as well. Methods: Systematic literature review of all PubMed citations between 1999 and August 2003 focusing on clinically relevant biochemical and physiological characteristics of ghrelin. Results: Ghrelin is an important component of an integrated regulatory system of growth and metabolism acting via the vagus nerve, and is implicated in a variety of altered energy states such as obesity, eating disorders, neoplasia, and cachexia. It also enhances immune responses and potentially down-regulates anti-inflammatory molecules. Ghrelin's role as a brain-gut peptide emphasizes the significance of afferent vagal fibers as a major pathway to the brain, serving the purpose of maintaining physiologic homeostasis. Conclusions: The discovery of ghrelin has increased our understanding of feeding regulation, nutritional homeostasis, and metabolic processes. Further characterization of ghrelin's functions will likely generate new pharmacological approaches to diagnose and treat different disease entities including those related to the over-nutrition of obesity and the catabolic response to surgical trauma.
引用
收藏
页码:464 / 474
页数:11
相关论文
共 117 条
[1]   Cardiac cachexia - A syndrome with impaired survival and immune and neuroendocrine activation [J].
Anker, SD ;
Coats, AJS .
CHEST, 1999, 115 (03) :836-847
[2]   Preliminary evidence that Ghrelin, the natural GH secretagogue (GHS)-receptor ligand, strongly stimulates GH secretion in humans [J].
Arvat, E ;
Di Vito, L ;
Broglio, F ;
Papotti, M ;
Muccioli, G ;
Dieguez, C ;
Casanueva, FF ;
Deghenghi, R ;
Camanni, F ;
Ghigo, E .
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2000, 23 (08) :493-495
[3]   Endocrine activities of ghrelin, a natural growth hormone secretagogue (GHS), in humans: Comparison and interactions with hexarelin, a nonnatural peptidyl GHS, and GH-releasing hormone [J].
Arvat, E ;
Maccario, M ;
Di Vito, L ;
Broglio, F ;
Benso, A ;
Gottero, C ;
Papotti, M ;
Muccioli, G ;
Dieguez, C ;
Casanueva, FF ;
Deghenghi, R ;
Camanni, F ;
Ghigo, E .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (03) :1169-1174
[4]   Ghrelin is an appetite-stimulatory signal from stomach with structural resemblance to motilin [J].
Asakawa, A ;
Inui, A ;
Kaga, T ;
Yuzuriha, H ;
Nagata, T ;
Ueno, N ;
Makino, S ;
Fujimiya, M ;
Niijima, A ;
Fujino, MA ;
Kasuga, M .
GASTROENTEROLOGY, 2001, 120 (02) :337-345
[5]   Antagonism of ghrelin receptor reduces food intake and body weight gain in mice [J].
Asakawa, A ;
Inui, A ;
Kaga, T ;
Katsuura, G ;
Fujimiya, M ;
Fujino, MA ;
Kasuga, M .
GUT, 2003, 52 (07) :947-952
[6]   A role of ghrelin in neuroendocrine and behavioral responses to stress in mice [J].
Asakawa, A ;
Inui, A ;
Kaga, T ;
Yuzuriha, H ;
Nagata, T ;
Fujimiya, M ;
Katsuura, G ;
Makino, S ;
Fujino, MA ;
Kasuga, M .
NEUROENDOCRINOLOGY, 2001, 74 (03) :143-147
[7]   Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3-kinase/AKT [J].
Baldanzi, G ;
Filigheddu, N ;
Cutrupi, S ;
Catapano, F ;
Bonissoni, S ;
Fubini, A ;
Malan, D ;
Baj, G ;
Granata, R ;
Broglio, F ;
Papotti, M ;
Surico, N ;
Bussolino, F ;
Isgaard, J ;
Deghenghi, R ;
Sinigaglia, F ;
Prat, M ;
Muccioli, G ;
Ghigo, E ;
Graziani, A .
JOURNAL OF CELL BIOLOGY, 2002, 159 (06) :1029-1037
[8]   Hyperleptinemia prevents increased plasma ghrelin concentration during short-term moderate caloric restriction in rats [J].
Barazzoni, R ;
Zanetti, M ;
Stebel, M ;
Biolo, G ;
Cattin, L ;
Guarnieri, G .
GASTROENTEROLOGY, 2003, 124 (05) :1188-1192
[9]   Structure-function studies on the new growth hormone-releasing peptide, ghrelin: Minimal sequence of ghrelin necessary for activation of growth hormone secretagogue receptor 1a [J].
Bednarek, MA ;
Feighner, SD ;
Pong, SS ;
McKee, KK ;
Hreniuk, DL ;
Silva, MV ;
Warren, VA ;
Howard, AD ;
Van der Ploeg, LHY ;
Heck, JV .
JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (23) :4370-4376
[10]   Growth hormone secretagogues and hypothalamic networks [J].
Bluet-Pajot, MT ;
Tolle, V ;
Zizzari, P ;
Robert, C ;
Hammond, C ;
Mitchell, V ;
Beauvillain, JC ;
Viollet, C ;
Epelbaum, J ;
Kordon, C .
ENDOCRINE, 2001, 14 (01) :1-8